VivoSim Labs, INC. (ticker: VIVS) is an NASDAQ-listed clinical research company. DredgeCap's structured extraction of VIVS's SEC filings surfaces 5 active risk signals, including 3 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. VIVS reported $91K in revenue and -$8.08M for the period ending 2025-12-31, with operating cash flow of -$8.59M. Cash and equivalents stood at $4.29M (up 269.3% year-over-year). Total assets of $6.96M exceed total liabilities of $2.52M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
VIVS Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for VivoSim Labs, INC. (VIVS) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.